We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Protein That Causes Damage in Early Brain Development Linked to Schizophrenia

By LabMedica International staff writers
Posted on 01 Dec 2014
Print article
Image: Structure of a typical neuron dendrite (Photo courtesy of Wikimedia Commons).
Image: Structure of a typical neuron dendrite (Photo courtesy of Wikimedia Commons).
Overexpression of a protein encoded by a susceptibility gene for schizophrenia was found to cause defective cortical patterning, which results in pathological structural changes in the developing brain.

The role of nitric oxide synthase 1 adaptor protein (NOS1AP) in the development of schizophrenia was studied in a rat model by investigators at Rutgers University (New Brunswick, NJ, USA). NOS1AP is cytosolic protein that binds to the signaling molecule, neuronal nitric oxide synthase (nNOS). This protein has a C-terminal PDZ-binding domain that mediates interactions with nNOS and an N-terminal phosphotyrosine binding (PTB) domain that binds to the small monomeric G protein, Dexras1. Studies have shown that this protein functions as an adapter protein linking nNOS to specific targets, such as Dexras1 and the synapsins.

Working with a rat model, the investigators knocked down or co-overexpressed NOS1AP and a GFP (green fluorescent protein) or TagRFP (red fluorescent protein) reporter in neuronal progenitor cells of the embryonic rat neocortex using an utero electroporation technique. They analyzed sections of cortex (ventricular zone, intermediate zone, and cortical plate containing GFP or TagRFP positive cells and counted the percentage of positive cells that migrated to each region from at least three rats for each condition.

Results published in the October 29, 2014, online edition of the journal Biological Psychiatry revealed that NOS1AP overexpression disrupted neuronal migration, resulting in increased cells in the intermediate zone and fewer cells in the cortical plate. An overabundance of NOS1AP also inhibited the process of dendritogenesis, neuronal growth during early brain development that is crucial to creating appropriate neural network structures necessary for all brain functions. In contrast, results from rats where NOS1AP production was "knocked down" showed increased neuronal migration, with more cells reaching the cortical plate.

"When the brain develops, it sets up a system of the right type of connectivity to make sure that communication can occur," said senior author Dr. Bonnie Firestein, professor of cell biology and neuroscience at Rutgers University. "What we saw here was that the nerve cells did not move to the correct locations and did not have dendrites that branch out to make the connections that were needed. The next step would be to let the disease develop in the laboratory and try to treat the over expression of the protein with an antipsychotic therapy to see if it works."

Related Links:

Rutgers University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.